Lyotropic Liquid Crystals (LLCs) are a class of lipid-based membranes with a strong potential for drug-delivery employment. The characterization and control of their transport properties is a central issue in this regard, and has recently prompted a notable volume of research on the topic. A promising experimental approach is provided by the so-called diffusion setup, where the drug molecules diffuse from a feeding chamber filled with water to a receiving one passing through a LLC. In the present work we provide a theoretical framework for the proper description of this setup, and validate it by means of targeted experiments. Due to the inhomogeneity of the system, a rich palette of different diffusion dynamics emerges from the interplay of the different time- and lengthscales thereby present. Our work paves the way to the employment of diffusion experiments to quantitatively characterize the transport properties of LLCs, and provides the basic tools for device diffusion setups with controlled kinetic properties.
REFERENCES
1.
N.
Garti
, P.
Somasundaran
, and R.
Mezzenga
, Self-Assembled Supramolecular Architectures: Lyotropic Liquid Crystals
(John Wiley & Sons
, 2012
), Vol. 3
.2.
J.
Barauskas
, M.
Johnsson
, and F.
Tiberg
, “Self-assembled lipid superstructures: Beyond vesicles and liposomes
,” Nano Lett.
5
, 1615
–1619
(2005
).3.
I.
Martiel
, N.
Baumann
, J. J.
Vallooran
, J.
Bergfreund
, L.
Sagalowicz
, and R.
Mezzenga
, “Oil and drug control the release rate from lyotropic liquid crystals
,” J. Controlled Release
204
, 78
–84
(2015
).4.
E. M.
Landau
and J. P.
Rosenbusch
, “Lipidic cubic phases: A novel concept for the crystallization of membrane proteins
,” Proc. Natl. Acad. Sci. U. S. A.
93
, 14532
–14535
(1996
).5.
C.
Fong
, T.
Le
, and C. J.
Drummond
, “Lyotropic liquid crystal engineering–ordered nanostructured small molecule amphiphile self-assembly materials by design
,” Chem. Soc. Rev.
41
, 1297
–1322
(2012
).6.
C.
Speziale
, L. S.
Manni
, C.
Manatschal
, E. M.
Landau
, and R.
Mezzenga
, “A macroscopic H+ and Cl− ions pump via reconstitution of EcClC membrane proteins in lipidic cubic mesophases
,” Proc. Natl. Acad. Sci. U. S. A.
113
, 7491
–7496
(2016
).7.
X.
Mulet
, B. J.
Boyd
, and C. J.
Drummond
, “Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions
,” J. Colloid Interface Sci.
393
, 1
–20
(2013
).8.
R.
Mezzenga
, P.
Schurtenberger
, A.
Burbidge
, and M.
Michel
, “Understanding foods as soft materials
,” Nat. Mater.
4
, 729
–740
(2005
).9.
R.
Negrini
and R.
Mezzenga
, “pH-responsive lyotropic liquid crystals for controlled drug delivery
,” Langmuir
27
, 5296
–5303
(2011
).10.
R.
Negrini
, W.-K.
Fong
, B. J.
Boyd
, and R.
Mezzenga
, “pH-responsive lyotropic liquid crystals and their potential therapeutic role in cancer treatment
,” Chem. Commun.
51
, 6671
–6674
(2015
).11.
R.
Negrini
and R.
Mezzenga
, “Diffusion, molecular separation, and drug delivery from lipid mesophases with tunable water channels
,” Langmuir
28
, 16455
–16462
(2012
).12.
A.
Zabara
and R.
Mezzenga
, “Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases
,” J. Controlled Release
188
, 31
–43
(2014
).13.
J. J.
Vallooran
, R.
Negrini
, and R.
Mezzenga
, “Controlling anisotropic drug diffusion in lipid-fe3o4 nanoparticle hybrid mesophases by magnetic alignment
,” Langmuir
29
, 999
–1004
(2013
).14.
E.
Nazaruk
, P.
Miszta
, S.
Filipek
, E.
Górecka
, E. M.
Landau
, and R.
Bilewicz
, “Lyotropic cubic phases for drug delivery: Diffusion and sustained release from the mesophase evaluated by electrochemical methods
,” Langmuir
31
, 12753
–12761
(2015
).15.
J.
Clogston
, G.
Craciun
, D.
Hart
, and M.
Caffrey
, “Controlling release from the lipidic cubic phase by selective alkylation
,” J. Controlled Release
102
, 441
–461
(2005
).16.
J.
Clogston
and M.
Caffrey
, “Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids
,” J. Controlled Release
107
, 97
–111
(2005
).17.
K. W.
Lee
, T.-H.
Nguyen
, T.
Hanley
, and B. J.
Boyd
, “Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs
,” Int. J. Pharm.
365
, 190
–199
(2009
).18.
S.
Phan
, W.-K.
Fong
, N.
Kirby
, T.
Hanley
, and B. J.
Boyd
, “Evaluating the link between self-assembled mesophase structure and drug release
,” Int. J. Pharm.
421
, 176
–182
(2011
).19.
J. J.
Vallooran
, S.
Bolisetty
, and R.
Mezzenga
, “Macroscopic alignment of lyotropic liquid crystals using magnetic nanoparticles
,” Adv. Mater.
23
, 3932
–3937
(2011
).20.
T.
Higuchi
, “Rate of release of medicaments from ointment bases containing drugs in suspension
,” J. Pharm. Sci.
50
, 874
–875
(1961
).21.
J.
Siepmann
and N. A.
Peppas
, “Higuchi equation: Derivation, applications, use and misuse
,” Int. J. Pharm.
418
, 6
–12
(2011
).22.
D. R.
Paul
, “Elaborations on the higuchi model for drug delivery
,” Int. J. Pharm.
418
, 13
–17
(2011
).23.
J. H.
Petropoulos
, K. G.
Papadokostaki
, and M.
Sanopoulou
, “Higuchi’s equation and beyond: Overview of the formulation and application of a generalized model of drug release from polymeric matrices
,” Int. J. Pharm.
437
, 178
–191
(2012
).24.
C.
Tittle
, “Boundary value problems in composite media: Quasi-orthogonal functions
,” J. Appl. Phys.
36
, 1486
–1488
(1965
).25.
G.
Pontrelli
and F.
de Monte
, “Mass diffusion through two-layer porous media: An application to the drug-eluting stent
,” Int. J. Heat Mass Transfer
50
, 3658
–3669
(2007
).26.
G.
Pontrelli
and F.
De Monte
, “A multi-layer porous wall model for coronary drug-eluting stents
,” Int. J. Heat Mass Transfer
53
, 3629
–3637
(2010
).27.
28.
B.
Boyd
, “Controlled release from cubic liquid-crystalline particles (cubosomes)
,” in Bicontinuous Liquid Crystals
, edited by M. L.
Lynch
and P. T.
Spicer
(Taylor & Francis Group
, 2005
), pp. 285
–304
.29.
E.
Nazaruk
, M.
Szlezak
, E.
Gorecka
, R.
Bilewicz
, Y. M.
Osornio
, P.
Uebelhart
, and E. M.
Landau
, “Design and assembly of ph-sensitive lipidic cubic phase matrices for drug release
,” Langmuir
30
, 1383
–1390
(2014
).30.
D.
Yariv
, R.
Efrat
, D.
Libster
, A.
Aserin
, and N.
Garti
, “In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems
,” Colloids Surf., B
78
, 185
–192
(2010
).31.
W. M.
Haynes
, CRC Handbook of Chemistry and Physics
(CRC Press
, 2014
).32.
A.
Einstein
, “Über die von der molekularkinetischen theorie der wärme geforderte bewegung von in ruhenden flüssigkeiten suspendierten teilchen
,” Ann. Phys.
322
, 549
–560
(1905
).33.
D. S.
Viswanath
, T. K.
Ghosh
, D. H.
Prasad
, N. V.
Dutt
, and K. Y.
Rani
, Viscosity of Liquids Theory, Estimation, Experiment, and Data
(Springer
, 2007
).34.
H. S.
Carslaw
and J. C.
Jaeger
, Conduction of Heat in Solids
, 2nd ed. (Clarendon Press
, Oxford
, 1959
).© 2016 Author(s).
2016
Author(s)
You do not currently have access to this content.
